12/19/2024
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:16 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:01 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
7:57 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
11:05 AM | Shuttle Pharmaceuticals (Filer)
| Form 424B4 | |
10/29/2024
11:15 PM | Shuttle Pharmaceuticals (Filer)
| Form EFFECT | |
|
10/29/2024
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
3:05 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
7:49 AM | Shuttle Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/25/2024
7:52 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
8:06 AM | Shuttle Pharmaceuticals (Filer)
| Form S-1/A | |
10/17/2024
4:17 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
4:00 PM | Jung Mira (Reporting)
Shuttle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
5:04 AM | Shuttle Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
09/13/2024
7:25 PM | Shuttle Pharmaceuticals (Filer)
| Form 424B3 | |
09/13/2024
4:00 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
4:23 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2024
3:26 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
8:51 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-K/A | |
09/03/2024
8:52 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-Q/A | |
09/03/2024
8:54 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/28/2024
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
5:08 AM | Shuttle Pharmaceuticals (Filer)
| Form NT 10-Q | |
08/07/2024
7:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
8:45 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2024
3:59 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
4:42 PM | Lorber Timothy J. (Reporting)
Shuttle Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/18/2024
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
5:12 AM | Shuttle Pharmaceuticals (Filer)
| Form PRE 14A | |
05/22/2024
3:15 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
4:01 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
9:05 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
3:36 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
4:06 PM | Shuttle Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/22/2024
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
5:07 AM | Shuttle Pharmaceuticals (Filer)
| Form 424B3 | |
03/21/2024
4:28 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2024
4:02 PM | Senanayake Chris (Reporting)
Shuttle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Vladimir Lenin was right… (Ad) The Magnificent 7 could be in for a world of pain…
And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock.
The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on.
It’s called The Final Frontier. Including the name of the #1 company to buy. |
03/08/2024
5:18 PM | Shuttle Pharmaceuticals (Issuer)
Vander Hoek Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
7:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
8:05 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
4:10 PM | Brown Milton (Reporting)
Shuttle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free SHPH Stock Alerts